Iatrogenic diversion of inferior vena cava to the left atrium presented as persistent hypoxemia: Case series

医源性下腔静脉改道至左心房导致持续性低氧血症:病例系列

阅读:1

Abstract

RATIONALE: The transcatheter closure and atrioseptopexy are the main treatment methods for atrial septal defect (ASD). However, persistent hypoxemia due to iatrogenic diversion of inferior vena cava (IVC) to the left atrium (LA) is reported as a rare complication after ASD closure. Contrast echocardiology is a reliable and powerful tool to detect iatrogenic diversion and identify the etiology accurately. PATIENT CONCERNS: We reported 2 patients (a 11-year-old boy [Patient 1] and a 39-year-old female [Patient 2]) with persistent hypoxemia and exertional dyspnea after ASD transcatheter closure and robotic atrioseptopexy, respectively. DIAGNOSES: Contrast echocardiography confirmed the presence of a right-to-left shunt at the atrial level which was presented only in femoral venous contrast injection instead of upper extremity venous contrast injection. INTERVENTIONS AND OUTCOMES: Subsequent surgical exploration found that the occluder straddling the entry of IVC and the fibrous membrane proliferating along the lower edge of the occlude in the first patient, and the patch improperly linked to the Eustachian valve in the second patient. The misoperation led to IVC partially draining into LA. After the surgeries, both of them had their hypoxic symptoms relieved. LESSONS: Persistent unexplained hypoxemia after ASD closure might be considered to result from a right-to-left shunt. An iatrogenic right-to-left shunt flow from the IVC to the LA was usually caused by the misplaced interatrial occluder or patch. Transthoracic agitated saline contrast echocardiography via combined peripheral venous access has the well-performed capability to hint some insidious right-to-left shunts and guides clinical therapy as soon as possible.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。